Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
166.41
Dollar change
+1.75
Percentage change
1.06
%
IndexS&P 500 P/E61.17 EPS (ttm)2.72 Insider Own0.11% Shs Outstand1.77B Perf Week2.54%
Market Cap294.65B Forward P/E13.69 EPS next Y12.15 Insider Trans-19.17% Shs Float1.77B Perf Month-5.59%
Income4.82B PEG9.65 EPS next Q2.26 Inst Own71.80% Short Float0.74% Perf Quarter1.00%
Sales54.32B P/S5.42 EPS this Y0.12% Inst Trans0.10% Short Ratio2.33 Perf Half Y11.48%
Book/sh5.87 P/B28.37 EPS next Y9.27% ROA3.52% Short Interest13.12M Perf Year3.23%
Cash/sh7.24 P/C22.99 EPS next 5Y6.34% ROE34.90% 52W Range130.96 - 182.89 Perf YTD7.38%
Dividend Est.6.23 (3.74%) P/FCF13.38 EPS past 5Y-5.77% ROI7.61% 52W High-9.01% Beta0.59
Dividend TTM6.06 (3.64%) Quick Ratio0.76 Sales past 5Y11.76% Gross Margin70.40% 52W Low27.07% ATR (14)3.30
Dividend Ex-DateApr 12, 2024 Current Ratio0.87 EPS Y/Y TTM-59.03% Oper. Margin37.04% RSI (14)39.73 Volatility1.56% 1.78%
Employees50000 Debt/Eq5.80 Sales Y/Y TTM-6.44% Profit Margin8.87% Recom2.00 Target Price184.49
Option/ShortYes / Yes LT Debt/Eq5.11 EPS Q/Q-67.09% Payout220.33% Rel Volume0.98 Prev Close164.66
Sales Surprise1.97% EPS Surprise-0.11% Sales Q/Q-5.42% EarningsApr 26 BMO Avg Volume5.64M Price166.41
SMA20-3.38% SMA50-5.13% SMA2006.74% Trades Volume5,532,224 Change1.06%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Upgrade William Blair Mkt Perform → Outperform
Dec-18-23Downgrade HSBC Securities Buy → Hold
Dec-11-23Upgrade Goldman Neutral → Buy
Nov-09-23Initiated Deutsche Bank Hold $150
Oct-30-23Upgrade Barclays Equal Weight → Overweight $160 → $170
Oct-20-23Resumed UBS Neutral $157 → $150
Sep-29-23Initiated Raymond James Outperform $177
Jul-25-23Initiated William Blair Mkt Perform
Jul-14-23Initiated HSBC Securities Buy $167
Apr-05-23Downgrade Argus Buy → Hold
Today 07:00AM
Apr-19-24 04:11PM
10:00AM
Apr-18-24 03:44PM
12:18PM
08:31AM Loading…
08:31AM
06:30AM
Apr-17-24 05:45PM
Apr-16-24 10:21AM
10:01AM
09:00AM
08:00AM
03:06AM
03:02AM
Apr-15-24 07:57AM
07:43AM Loading…
07:43AM
Apr-14-24 01:23AM
Apr-13-24 12:18PM
Apr-12-24 04:19PM
07:30AM
Apr-11-24 05:45PM
07:02AM
Apr-10-24 10:53AM
Apr-09-24 08:00AM
07:13AM
04:21AM
Apr-08-24 05:50PM
09:19AM
Apr-06-24 06:49AM
Apr-05-24 05:45PM
09:00AM Loading…
09:00AM
08:00AM
06:39AM
Apr-04-24 06:52PM
08:00AM
Apr-03-24 08:48AM
08:30AM
Apr-02-24 12:41PM
10:28AM
08:00AM
03:36AM
Apr-01-24 05:45PM
07:50AM
04:30AM
Mar-31-24 11:52AM
Mar-30-24 05:19AM
Mar-29-24 12:16PM
Mar-28-24 01:38PM
Mar-27-24 10:00AM
Mar-26-24 10:03AM
08:36AM
06:18AM
04:56AM
Mar-25-24 05:45PM
01:27PM
12:58PM
12:40PM
11:45AM
11:00AM
09:25AM
09:00AM
08:39AM
08:37AM
08:31AM
08:05AM
Mar-24-24 03:54PM
11:04AM
Mar-22-24 07:00PM
03:10PM
03:02PM
02:35PM
Mar-21-24 10:25AM
10:00AM
08:00AM
Mar-19-24 05:45PM
08:32AM
08:00AM
08:00AM
Mar-17-24 08:15AM
Mar-14-24 09:38AM
08:18AM
Mar-13-24 05:45PM
08:17AM
06:30AM
Mar-12-24 01:20PM
09:00AM
08:33AM
08:09AM
Mar-11-24 06:21PM
04:25PM
09:28AM
Mar-10-24 10:18AM
10:00AM
Mar-09-24 02:59AM
Mar-08-24 04:20PM
11:45AM
04:34AM
Mar-07-24 05:45PM
08:00AM
Mar-06-24 08:03AM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERMar 20 '24Sale176.3021,0823,716,75755,903Mar 22 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Option Exercise61.3626,1101,602,110119,890Mar 20 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Sale178.7958,94910,539,50860,941Mar 20 05:00 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Option Exercise61.3645,7002,804,15289,517Mar 05 05:30 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Sale177.2775,68013,415,50313,837Mar 05 05:30 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Option Exercise58.3021,5601,257,012167,524Mar 01 05:50 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Sale176.4568,87912,153,95798,645Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 29 '24Sale177.399,8911,754,55510,397Mar 01 05:50 PM
Buckbee Kevin KSVP, CONTROLLERFeb 29 '24Sale176.655,144908,6886,983Mar 01 05:50 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOFeb 28 '24Sale177.27138,61624,572,458519,099Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Option Exercise137.3613,7531,889,11541,926Feb 27 05:10 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Option Exercise61.3614,140867,63041,205Mar 01 05:50 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Sale177.4414,1402,509,00227,065Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Sale177.5113,7532,441,29528,173Feb 27 05:10 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Option Exercise58.8852,8703,112,986296,814Feb 23 05:00 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Sale173.7152,8709,184,048243,944Feb 23 05:00 PM
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERDec 26 '23Sale154.722,912450,54555,903Dec 28 05:00 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOAug 01 '23Sale148.5860,0008,914,800565,294Aug 02 05:07 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOJul 31 '23Sale149.1518,5002,759,275625,294Aug 02 05:07 PM
Sorg Elaine K.SVP, US COMMERCIAL OPERATIONSApr 25 '23Option Exercise144.546,130886,03041,460Apr 27 05:00 PM
Sorg Elaine K.SVP, US COMMERCIAL OPERATIONSApr 25 '23Sale165.006,1301,011,45035,330Apr 27 05:00 PM